Literature DB >> 26913208

Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Co-Infection Among HIV Infected Individuals at Tertiary Care Hospital in Western Nepal.

Hosuru Subramanya Supram1, Shishir Gokhale1, Brijesh Sathian2, Dharma Raj Bhatta1.   

Abstract

BACKGROUND: The HIV, HBV and HCV viruses are the major public health concern all over the world including Nepal. The aim of the study is to determine the rate of HBV and HCV co-infections in patients with HIV infection.
METHODS: The study cohort included 218 consecutive HIV infected patients who were examined for co-infection with HBV or HCV or both at Manipal teaching hospital, Western Nepal. The demographic data of the subjects was collected retrospectively. The data was analyzed with SPSS software and EPI Info to measure the correlation of variables and infection rates.
RESULTS: In the course of six years study period, a total of 25,708 samples were collected for HIV screening test. The 218 (0.8%) screen test positive for HIV were confirmed as per WHO guidelines. The overall rate of co-infection with HBV and or HCV was 7.3% (16 of 218 patients). Only 7 (3.2% [CI 1.3, 6.5]) were positive for both HIV and HBV infection markers and 9 (4.1% [CI 1.9, 7.7]) were positive for HIV and HCV infection markers. None were positive of all three virus markers.
CONCLUSION: It is advisable to implementregular screening for Hepatitis B Virus and Hepatitis C Virus among all HIV infected individuals and their sexual partners.

Entities:  

Keywords:  Co-infection; HBV; HCV; HIV

Year:  2015        PMID: 26913208      PMCID: PMC4727548          DOI: 10.3126/nje.v5i2.12831

Source DB:  PubMed          Journal:  Nepal J Epidemiol


  15 in total

1.  Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy.

Authors:  Andrew M Musyoki; Thembeni L Msibi; Mojakgomo H Motswaledi; Selokela G Selabe; Tshweu S Monokoane; M Jeffrey Mphahlele
Journal:  J Med Virol       Date:  2014-08-25       Impact factor: 2.327

2.  HIV-HBV coinfection--a global challenge.

Authors:  Athena P Kourtis; Marc Bulterys; Dale J Hu; Denise J Jamieson
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

3.  Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study.

Authors:  M Hofer; H I Joller-Jemelka; P J Grob; R Lüthy; M Opravil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

4.  Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.

Authors:  Won-Long Chuang; Chia-Yen Dai; Wen-Yu Chang; Li-Po Lee; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
Journal:  Antivir Ther       Date:  2005

5.  Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa.

Authors:  Samar Ben Halima; Olfa Bahri; Nadia Maamouri; Imed Cheikh; Nissaf Ben Alaya; Amel Sadraoui; Ons Azaiez; Msaddak Azouz; Nabyl Ben Mami; Henda Triki
Journal:  Virol J       Date:  2010-09-15       Impact factor: 4.099

6.  Seroprevalence of HIV and hepatitis C co-infection among blood donors in Kathmandu Valley, Nepal.

Authors:  Surendra Karki; Prakash Ghimire; Bishnu Raj Tiwari; Ashish Chandra Shrestha; Avhishekh Gautam; Manita Rajkarnikar
Journal:  Southeast Asian J Trop Med Public Health       Date:  2009-01       Impact factor: 0.267

7.  Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.

Authors:  Gia L Tyson; Jennifer R Kramer; Zhigang Duan; Jessica A Davila; Peter A Richardson; Hashem B El-Serag
Journal:  Hepatology       Date:  2013-07-01       Impact factor: 17.425

8.  HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study.

Authors:  Fujie Zhang; Hao Zhu; Yasong Wu; Zhihui Dou; Yao Zhang; Nora Kleinman; Marc Bulterys; Zunyou Wu; Ye Ma; Decai Zhao; Xia Liu; Hua Fang; Jing Liu; Wei-Ping Cai; Hong Shang
Journal:  Lancet Infect Dis       Date:  2014-10-07       Impact factor: 25.071

9.  Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.

Authors:  Beatrice Mukami Muriuki; Michael Muita Gicheru; Dorcas Wachira; Anthony Kebira Nyamache; Samoel Ashimosi Khamadi
Journal:  BMC Res Notes       Date:  2013-09-09

10.  Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.

Authors:  Warda Baha; Abderrahim Foullous; Noureddine Dersi; Thierry Paluku They-they; Khadija El alaoui; Nadia Nourichafi; Bouchra Oukkache; Fatiha Lazar; Soumaya Benjelloun; My Mustapha Ennaji; Abdelouhad Elmalki; Hassan Mifdal; Abdelouaheb Bennani
Journal:  BMC Public Health       Date:  2013-01-18       Impact factor: 3.295

View more
  4 in total

1.  Hepatitis C virus genotypes in Saudi Arabia: a future prediction and laboratory profile.

Authors:  Amen Bawazir; Fahad AlGusheri; Hoda Jradi; Mohammed AlBalwi; Abdel-Galil Abdel-Gader
Journal:  Virol J       Date:  2017-11-02       Impact factor: 4.099

2.  Late Response of Antiretroviral Therapy in an HIV-1-Infected Patient due to Hepatitis B and C Coinfections: The First Case Report in Nepal.

Authors:  Sundar Khadka; Rupendra Shrestha; Sanjeet Pandit; Roshan Pandit; Anup Bastola
Journal:  Case Rep Med       Date:  2019-02-11

3.  Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.

Authors:  Manjula Bhattarai; Jagat Bahadur Baniya; Nirmal Aryal; Bimal Shrestha; Ramanuj Rauniyar; Anurag Adhikari; Pratik Koirala; Pardip Kumar Oli; Ram Deo Pandit; David A Stein; Birendra Prasad Gupta
Journal:  Biomed Res Int       Date:  2018-01-02       Impact factor: 3.411

Review 4.  Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973-2017).

Authors:  Marcelo Contardo Moscoso Naveira; Komal Badal; Jagadish Dhakal; Neichu Angami Mayer; Bina Pokharel; Ruben Frank Del Prado
Journal:  Hepatol Med Policy       Date:  2018-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.